Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study.
文献类型：期刊论文
| 作者 | Huang, Shuang; Chen, Xiaozhong; Qu, Song; Qu, Shenhong; Han, Yaqian; Yang, Kunyu; Huang, Shiting; Li, Min; Zhang, Lin; Ding, Qian |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000863680303608 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129781]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 2.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China 3.Huazhong Univ Sci Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China 4.Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China 5.Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China 6.Hunan Canc Hosp, Changsha, Peoples R China |
| 推荐引用方式 GB/T 7714 | Huang, Shuang,Chen, Xiaozhong,Qu, Song,et al. Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Huang, Shuang.,Chen, Xiaozhong.,Qu, Song.,Qu, Shenhong.,Han, Yaqian.,...&Ding, Qian.(2022).Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Huang, Shuang,et al."Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。